EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikaz 51 - 100 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
turpentine, oil Any of the volatile predominately terpenic fractions or distillates resulting from the solvent extraction of, gum collection from, or pulping of softwoods. Composed primarily of the C10H16 terpene hydrocarbons: α-pinene, β-pinene, limonene, 3-carene, camphene. May contain other acyclic, monocyclic, or bicyclic terpenes, oxygenated terpenes, and anethole. Exact composition varies with refining methods and the age, location, and species of the softwood source.	232-350-7	8006-64-2	Flam. Liq. 3; Acute Tox. 4; Asp. Tox. 1; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1		Details
trypsin	232-650-8	9002-07-7	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1		Details
troclosene sodium, dihydrate	610-700-3	51580-86-0	Acute Tox. 4; Eye Irrit. 2; STOT SE 3		Details
troclosene sodium	220-767-7	2893-78-9	Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3		Details
troclosene potassium	218-828-8	2244-21-5	Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3		Details
trizinc diphosphide; zinc phosphide	215-244-5	1314-84-7	Water-react. 1; Acute Tox. 2		Details
trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	R Toxic for reproduction (article 57c)	Details
tritosulfuron (ISO) (containing ≤0,02 % AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)	604-291-0	142469-14-5	Skin Sens. 1		Details
triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol	-	138182-18-0	Repr. 2; STOT RE 2		Details
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) REACTIVE BLUE 245	407-580-8	130201-51-3	Eye Dam. 1		Details
Trisodium orthoborate	238-253-6	14312-40-4		R Toxic for reproduction (article 57c)	Details
trisodium nitrilotriacetate	225-768-6	5064-31-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2		Details
trisodium N-(3-propionato)-l-aspartate	422-090-4	172737-80-3	Eye Dam. 1		Details
trisodium N, N-bis(carboxymethyl)-β-alanine TRILON(R) ES 9851	414-070-9	129050-62-0	Skin Corr. 1B		Details
trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate TRILON(R) ES 9910	414-130-4	119710-96-2	Acute Tox. 4		Details
trisodium hexafluoroaluminate(cryolite)	239-148-8	15096-52-3	STOT RE 1; Acute Tox. 4		Details
trisodium hexafluoroaluminate	237-410-6	13775-53-6	STOT RE 1; Acute Tox. 4		Details
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) RED JB 747	418-220-4	-	Skin Sens. 1		Details
trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) BI 3277; NOIR CORSE SANODAL H3LW CONC.; SANODAL DEEP BLACK H-3LW CONC.; SANODAL TIEFSCHWARZ H-3LW; SANODAL TIEFSCHWARZ H-3LW KONZ.	400-810-8	106084-79-1	Muta. 2		Details
trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) ACID BLUE 349; AZO-METALCOMPLEX-BLUE AP 1149; BLEU ACIDE 349; C.I. ACID BLUE 349; SELLASET BLEU H; SELLASET BLUE H	402-870-0	93952-24-0	Eye Dam. 1		Details
trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato2-naphthylazo)-biphenyl 1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) SOLAMINLICHTBLAU VGRL 133	413-590-3	164058-22-4	Carc. 1B		Details
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 TURQUOISE 10 40 518	411-430-7	-	Eye Dam. 1; Skin Sens. 1		Details
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III)	423-100-1	-	Eye Dam. 1		Details
trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulphonate C.I. REACTIVE YELLOW 174; GIALLO REATTIVO 174; JAUNE REACTIF 174; REAKTIV GELB 174	402-170-5	106359-91-5	Skin Sens. 1		Details
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate	440-480-2	341026-59-3	Eye Dam. 1; Skin Sens. 1		Details
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate	430-280-3	844491-96-9	Skin Sens. 1		Details
trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate BLEU REACTIF CAC 10; DIOXAZINE MONCHLORTRIAZINE; FAT NO. 40 407; REACTIVE BLUE CAC 10	410-130-3	136248-03-8	Skin Sens. 1		Details
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate	429-240-8	212652-59-0	Eye Dam. 1		Details
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate	427-710-7	215612-56-9	Eye Dam. 1; Skin Sens. 1		Details
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex BLUE TZ 4312	423-770-3	-	Eye Dam. 1		Details
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate SCARLET 12 04 262	406-820-9	159317-41-6	Eye Irrit. 2		Details
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) SÄUREBLAU 82 226	402-500-8	104105-46-6	Eye Dam. 1		Details
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) BROWN 1612969	407-110-1	480445-87-2	Eye Dam. 1; Skin Sens. 1		Details
tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2		Details
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate LEXMARK YELLOW DYE 415; PRISM YELLOW	406-073-9	131013-81-5	Acute Tox. 3		Details
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) PIGMENTBLAU 1755	403-210-4	108300-90-9	Eye Dam. 1		Details
tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1	ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
Tris(4-nonylphenyl, branched) phosphite show/hide Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4 Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7 Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: -	799-976-5	-		ENDE Endocrine disrupting properties (Article 57(f) - environment)	Details
tris(2-methoxyethoxy)vinylsilane; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	213-934-0	1067-53-4	Repr. 1B	R Toxic for reproduction (article 57c)	Details
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4	R Toxic for reproduction (article 57c)	Details
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate ACETOACETYLORTHOSINIC ACID, A6-SALT	403-760-5	68030-79-5	Skin Sens. 1		Details
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate	-	7276-58-6	Acute Tox. 4		Details
tripropyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3		Details
tripropylammonium dihydrogenphosphate TRYPROPYLAMMONIUM DIHYDROGENPHOSPHAT	433-700-3	35687-90-2	Acute Tox. 4		Details
triphenyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3		Details
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3; Eye Dam. 1		Details
triphenyl phosphite	202-908-4	101-02-0	Eye Irrit. 2; Skin Irrit. 2		Details
trioctyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2		Details
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Skin Irrit. 2		Details
trinickel tetrasulfide	-	12137-12-1	Carc. 1A; STOT RE 1; Skin Sens. 1		Details

Prikaz 51 - 100 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items